(Q42916316)

English

Licensing drugs for diabetes

scientific article published on 6 September 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 November 2017

0 references

Licensing drugs for diabetes (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 November 2017

3

Harlan Krumholz

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 November 2017

1

Richard Lehman

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 November 2017

John S Yudkin

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

language of work or name

English

0 references

publication date

6 September 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

volume

341

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

page(s)

c4805

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

Identifiers

DOI

10.1136/BMJ.C4805

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

PubMed publication ID

20819887

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20819887

retrieved

11 November 2017

(Q42916316)

Licensing drugs for diabetes

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)